| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/01/2009 | CA2719477A1 Hydroxamate-based inhibitors of deacetylases b |
| 10/01/2009 | CA2719243A1 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same |
| 10/01/2009 | CA2719202A1 Anti-tumor agent comprising cytidine derivative and carboplatin |
| 10/01/2009 | CA2718321A1 Human anti-mesothelin monoclonal antibodies |
| 10/01/2009 | CA2716961A1 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 10/01/2009 | CA2716932A1 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 10/01/2009 | CA2716884A1 Use of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc) in combination with cyclophosphamide, vincristine and doxorubicine for treating non-hodgkin's lymphomas |
| 10/01/2009 | CA2716882A1 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 10/01/2009 | CA2716726A1 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors |
| 10/01/2009 | CA2716088A1 Quinazolinone derivatives as tubulin polymerization inhibitors |
| 10/01/2009 | CA2712535A1 An anti-cancer cytotoxic monoclonal antibody |
| 09/30/2009 | EP2105502A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/30/2009 | EP2105501A1 Novel immunotherapy against neuronal and brain tumors |
| 09/30/2009 | EP2105449A2 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 09/30/2009 | EP2105448A2 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 09/30/2009 | EP2105141A1 Short bioactive peptides and methods for their use |
| 09/30/2009 | EP2105140A1 Anticancer agent |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2104737A2 Functions and targets of let-7 micro rnas |
| 09/30/2009 | EP2104732A1 Cancerous disease modifying antibodies |
| 09/30/2009 | EP2104673A2 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 09/30/2009 | EP2104672A2 2-(piperidin-4-yl0xy)pyrimidin-4-amine derivatives as deoxycytidine kinase inhibitors for the treatment of cancer |
| 09/30/2009 | EP2104670A2 Novel triazinedione derivatives as gaba-b receptor modulators |
| 09/30/2009 | EP2104669A2 Inhibitors of akt activity |
| 09/30/2009 | EP2104664A1 Tetrahydrobenzoisoxazole - and tetrahydroindazole derivatives as modulators of the mitotic motor protein |
| 09/30/2009 | EP2104513A2 Ovr110 antibody compositions and methods of use |
| 09/30/2009 | EP2104504A2 Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 09/30/2009 | EP2104502A1 Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives |
| 09/30/2009 | EP1940844B1 Compounds and compositions as protein kinase inhibitors |
| 09/30/2009 | EP1739186B1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor |
| 09/30/2009 | EP1530465B1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 09/30/2009 | EP1453525B1 Selective targeting of apoptotic cells |
| 09/30/2009 | EP1451322B1 Il-21 antagonists |
| 09/30/2009 | EP1389122B1 Prevention of epithelial cancer |
| 09/30/2009 | EP1342085B1 Non-apoptotic forms of cell death and methods of modulation |
| 09/30/2009 | EP1309627B1 Immunotherapy for chronic myelocytic leukemia with naked anti-nca-90 antibody |
| 09/30/2009 | EP1286689B1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 09/30/2009 | EP1037649B1 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 09/30/2009 | CN101547699A Bile preparations for colorectal disorders |
| 09/30/2009 | CN101544998A Separation and purification preparation method and antineoplastic activity of tea polysaccharide |
| 09/30/2009 | CN101544953A Oxytropis Ehrig cinerea FEL2-OG and separation method and application thereof |
| 09/30/2009 | CN101544952A Oxytropis ehrig cinerea FEL4-OOc and separation method and application thereof |
| 09/30/2009 | CN101544697A Fusion protein TT-B7-H4IgV as well as preparation method and application thereof |
| 09/30/2009 | CN101544696A Compound containing pigment epidermal derived factors and preparation method and application thereof |
| 09/30/2009 | CN101544694A Anti-CD20 tetravalent antibody and preparation method and application thereof |
| 09/30/2009 | CN101544693A Recombined extrasin alpha 1 two-strand body protein and preparation method thereof |
| 09/30/2009 | CN101544681A New anti-tumor compound holothuria nobilis selenka saponin octyl of holothuria nobilis selenka |
| 09/30/2009 | CN101544680A New anti-tumor compound holothuria nobilis selenka saponin nonan of holothuria nobilis selenka |
| 09/30/2009 | CN101544678A Formulation and use of ergosta-7,22-dien-3beta-ol |
| 09/30/2009 | CN101544652A Thiourea homologues epipodophyllotoxin compound and preparation method and application thereof |
| 09/30/2009 | CN101544642A 4-pteridine-ammonia compound and preparation and application thereof |
| 09/30/2009 | CN101544634A 2-phenyl-3-substituted pyrazolo[1,5-a]pyridine derivatives, preparation method and application thereof |
| 09/30/2009 | CN101544631A Novel pyrazole 5-lipoxygenase small molecule inhibitors, preparation method, pharmaceutical composition and application thereof |
| 09/30/2009 | CN101544622A Method for semi-synthesizing taxol via 9-dihydro-13-acetyl baccatin III |
| 09/30/2009 | CN101544609A Crystallization form of 4-anilinoquinazoline derivatives |
| 09/30/2009 | CN101544556A Quinone compound Bostrycin, preparation method thereof and anti-tumor application thereof |
| 09/30/2009 | CN101543632A Anti-tumor prodrug having accurate structure and taking novel amphipathic polymer as carrier and synthetic method thereof |
| 09/30/2009 | CN101543625A Use of CENP-E binding protein and its coding gene in preparing medicine for suppressing tumor proliferation |
| 09/30/2009 | CN101543616A Traditional Chinese medicine composition for preventing and treating tumor and its preparation method |
| 09/30/2009 | CN101543614A Cancer treating oral liquid and preparation method thereof |
| 09/30/2009 | CN101543613A Cancerocidal pill and preparation method thereof |
| 09/30/2009 | CN101543612A Chinese medicament for treating malignant lymphoma |
| 09/30/2009 | CN101543609A Traditional Chinese medicine for treating breast cancer and preparation method thereof |
| 09/30/2009 | CN101543608A Medicine composition for adjuvant treatment of breast cancer and preparation method thereof |
| 09/30/2009 | CN101543597A Medicine composition for nourishing spleen and kidney and building up healthful vital energy and preparation method thereof |
| 09/30/2009 | CN101543595A Medicine for treating cancer and method for preparing same |
| 09/30/2009 | CN101543585A Chinese medicament for controlling and treating skin cancer |
| 09/30/2009 | CN101543571A Rhizoma paridis total aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543570A Smilax glabra total aglycone oral pharmaceutical preparation as well as preparation method and application thereof |
| 09/30/2009 | CN101543568A Yam total sapogenin sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543566A Medicine composition for curing breast cancer and preparation method thereof |
| 09/30/2009 | CN101543561A Traditional Chinese medicine preparation for treating breast cancer |
| 09/30/2009 | CN101543546A Antioxidative substance and composition and use thereof |
| 09/30/2009 | CN101543533A Medicament for treating leukemia |
| 09/30/2009 | CN101543526A Kudzu root total aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543518A Ginseng stem leaf total sapogenin oral pharmaceutical preparation as well as preparation method and application thereof |
| 09/30/2009 | CN101543517A Folium ginkgo total flavonoid aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543490A Application of genistein in medicament preparation for treating hyperplasia of prostate, product and producing method |
| 09/30/2009 | CN101543488A A medicine containing caffeic acid 3,4-dihydroxyl phenethyl ester and its uses |
| 09/30/2009 | CN101543484A Transdermal drug delivery preparation containing chitin or derivate thereof and preparation method thereof |
| 09/30/2009 | CN101543478A Boanmycin freeze-dry powder injection and preparation method thereof |
| 09/30/2009 | CN101543476A A naringin solid dispersion and the preparation method, and the application thereof |
| 09/30/2009 | CN101543473A Micro-emulsion composition of etoposide oral medicament, preparation method and application thereof |
| 09/30/2009 | CN101543472A Method for preparing oxaliplatin sustained release suppository |
| 09/30/2009 | CN101543298A Rutin chewing agent and method for preparing same |
| 09/30/2009 | CN100545174C Compositions and methods for wt1 specific immunotherapy |
| 09/30/2009 | CN100545161C Heterocyclic derivatives their preparing methods and uses |
| 09/30/2009 | CN100544770C Method for detecting and killing epithelial cancer cells |
| 09/30/2009 | CN100544715C Composition of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/30/2009 | CN100544714C Composition for solubilization of paclitaxel and preparation method thereof |
| 09/30/2009 | CN100544713C Paclitaxel mixed composition and water-in-oil type emulsion formulation for chemoembolization and preparation method thereof |
| 09/29/2009 | US7595401 6-amino-9H-purines as anticancer agents; 9-[2-(1-Acetylpiperridin-4-yl)ethyl]-8-[(6-bromo-1,3-benzodioxol-5-yl)thio]-9H-purin-6-amine for example |
| 09/29/2009 | US7595400 Synthesis of antitumor agents including camptothecin derivative 9-ethyl-9-hydroxy-1-pentyl-1H,12H-pyrano[3'',4'':6',7']-indolizino[1',2':6,5]pyrido[4,3,2-de]quinazoline-10,13(9H,15H)-dione |
| 09/29/2009 | US7595343 Inhibitors of histone deacetylase |
| 09/29/2009 | US7595334 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 09/29/2009 | US7595326 1-[4-(5-Bromopyrimidin-2-ylsulfanyl)phenyl]-3-(2-nitrobenzoyl)-urea; antiproliferative, water soluble compound with high bioavailability |
| 09/29/2009 | US7595325 1-[5-(4-Amino-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-pyridin-3-yl]-3-(2-fluoro-5-methyl-phenyl)-urea; cancer |
| 09/29/2009 | US7595192 Obtained by inducing necrosis by temperature in tumor cells and lysing the necrotic tumor cells; vaccines against cancers, tumorous diseases, infections and/or autoimmune diseases |